NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/23/2024
Back to search
Official data from USPTO
TAKE2
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
TAKE2
ST13
US500000097261874Class
1, 5, 9, 10
Filing
97261874
Registration
7283042
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
01/23/2024
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
02/10/2022
Registration date
01/23/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/23/2024
Last transaction
01/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Hong Kong, HK
Examiner
NADELMAN, ANDREA KOYNER
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Take2 Health Limited
Representatives
Tama L. Drenski RENNER KENNER GREIVE BOBAK TAYLOR & WEBER CO. LPA
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
(Based on 44(e)) Chemicals used in industry and science; assays and reagents for scientific and research useassays and reagents for use in genetic researchassays for research purposesreagents for scientific and research use; diagnostic reagents for scientific use; diagnostic preparations for scientific use; diagnostic test kits for use in the fields of scientificpharmaceutical and medical researchdiagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents to monitor toxicity of drugs; diagnostic test kits for scientific usekits comprised of diagnostic reagents and preparations for scientific use; chemical reagents for non-medical purposes; chemical test kits for analysis and detection of genetic information and diseases for scientificclinical or medical laboratory use; chemical reagents and kits containing sameeach for scientific purposes; reagentsenzymesnucleotides for medical research use; Chemical preparations for pharmaceutical or medical purposesfor chemical additives for use in the manufacture of pharmaceuticals for cancer
Class 5
(Based on 44(e)) Pharmaceuticalmedical and veterinary preparationschemical preparations for pharmaceutical or medical purposesfor treating cancermedical preparations for the treatment of cancerpharmaceutical products for the treatment of cancer; medical diagnostic reagents; clinical diagnostic reagentsreagents for use in medical genetic testing; reagentsenzymesnucleotides for use in genetic testing for medical and diagnostic purposesreagents for medical usediagnostic reagents for medical useenzymes for medical purposesreagents for medical use and medical diagnostic reagentsscreening kits comprised of reagents for medical diagnostics and for medical screening use; reagent kits composed of medical diagnostic reagents and medical diagnostic reagent beads with attached biomolecules for clinical diagnostic purposes; diagnostic tests and test kits for determination of genetic information for medical purposesgenetic identity tests comprised of reagents for medical purposes; pharmaceutical products for ophthalmological usefor the treatment of cancerfor treating diabetesfor the treatment of bone disease; diagnostic medical reagents for medical use; medical diagnostic test kitsmedical diagnostic preparations and screening kits comprised of reagents for medical diagnostics and medical screening usediagnostic kits comprised of medical diagnostic reagents and assays for use in disease detectioncancer
Class 9
(Based on 44(e)) Automated laboratory apparatus for use in analysis of biomolecules for scientific purposes; nucleic acid sequencers for scientific purposes; non-medical imaging devices for gemstonesrootsfor clinical diagnostic purposes and scientific research; laboratory equipmentcupelsfunnelsmicroarrayselectric bath heaters; scientific equipment and instrumentsultra-high vacuum champers and scientific apparatus and instruments for measuring relative DNARNA and protein and parts and fittings therefor; DNA testing apparatus which carry or hold DNA samples for non-medical purposes; Ophthalmic instrumentsophthalmic lenses
Class 10
(Based on 44(e)) Surgical apparatus and instruments for medical useincubators for medical purposesapparatus for use in medical analysismedical diagnostic instruments for the analysis of body fluids; and ophthalmic instrumentslasers for ophthalmic purposes; medical diagnostic apparatusultrasonic medical diagnostic apparatus and hematology analyzers for medical diagnostic uses; analytical apparatus for medical purposesmedical instruments for analyzing bacteria and breath gas analyzers for medical diagnostics; medical apparatus for detecting cancer; cholesterol meters; endoscopic equipment for medical purposes; enema apparatus for medical purposes; physical exercise apparatusfor medical purposes; gloves for medical purposes; magnetic resonance imaging apparatus for medical purposes; massage apparatus for medical purposes; medical apparatus and instruments for detecting and treating cancer; DNA testing apparatus which carry or hold DNA samples for medical purposes
Publications
History of USPTO decisions and trademark events.
33 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/23/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
12/14/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/14/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/14/2023
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
11/14/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/19/2023
PUBO
PUBLISHED FOR OPPOSITION
09/19/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/30/2023
OTHE
CASE RETURNED TO EXAMINATION
08/16/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/16/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/16/2023
PUBO
PUBLISHED FOR OPPOSITION
05/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/26/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/13/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/21/2022
GNRT
NON-FINAL ACTION E-MAILED
11/21/2022
CNRT
NON-FINAL ACTION WRITTEN
11/21/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/26/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/26/2022
ALIE
ASSIGNED TO LIE
10/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/14/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/22/2022
GNRT
NON-FINAL ACTION E-MAILED
03/22/2022
CNRT
NON-FINAL ACTION WRITTEN
03/22/2022
DOCK
ASSIGNED TO EXAMINER
03/18/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/15/2022
NWAP
NEW APPLICATION ENTERED
02/14/2022
Continuous trademark protection
Get notified about every new filing that threatens TAKE2 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.